Improved Mass Spectrometry-based methods reveal abundant propionylation and tissue specific histone propionylation profiles.


Journal

Molecular & cellular proteomics : MCP
ISSN: 1535-9484
Titre abrégé: Mol Cell Proteomics
Pays: United States
ID NLM: 101125647

Informations de publication

Date de publication:
10 Jun 2024
Historique:
received: 03 08 2023
revised: 07 05 2024
accepted: 09 06 2024
medline: 13 6 2024
pubmed: 13 6 2024
entrez: 12 6 2024
Statut: aheadofprint

Résumé

Histone post-translational modifications (PTMs) have crucial roles in a multitude of cellular processes, and their aberrant levels have been linked with numerous diseases, including cancer. Although histone PTM investigations have focused so far on methylations and acetylations, alternative long-chain acylations emerged as new dimension, as they are linked to cellular metabolic states and affect gene expression through mechanisms distinct from those regulated by acetylation. Mass spectrometry (MS) is the most powerful, comprehensive and unbiased method to study histone PTMs. However, typical MS-based protocols for histone PTM analysis do not allow identification of naturally occurring propionylation and butyrylation. Here, we present improved state-of-the-art sample preparation and analysis protocols to quantitate these classes of modifications. After testing different derivatization methods coupled to protease digestion, we profiled common histone PTMs and histone acylations in seven mouse tissues and human normal and tumor breast clinical samples, obtaining a map of propionylations and butyrylations found in different tissue contexts. A quantitative histone PTM analysis also revealed a contribution of histone acylations in discriminating different tissues, also upon perturbation with antibiotics, and breast cancer samples from the normal counterpart. Our results show that profiling only classical modifications is limiting and highlight the importance of using sample preparation methods that allows the analysis of the widest possible spectrum of histone modifications, paving the way for deeper insights into their functional significance in cellular processes and disease states.

Identifiants

pubmed: 38866077
pii: S1535-9476(24)00089-6
doi: 10.1016/j.mcpro.2024.100799
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100799

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Alessandro Vai (A)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, 20139, Milan, Italy.

Roberta Noberini (R)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, 20139, Milan, Italy.

Chiara Ghirardi (C)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, 20139, Milan, Italy.

Dieggo Rodrigues de Paula (D)

International Laboratory for Microbiome Host Epigenetics, Department of Genetics, Evolution, Microbiology, and Immunology, Institute of Biology, University of Campinas, Campinas, SP 13083-862, Brazil.

Michele Carminati (M)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, 20139, Milan, Italy.

Rani Pallavi (R)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, 20139, Milan, Italy.

Nathália Araújo (N)

International Laboratory for Microbiome Host Epigenetics, Department of Genetics, Evolution, Microbiology, and Immunology, Institute of Biology, University of Campinas, Campinas, SP 13083-862, Brazil.

Patrick Varga-Weisz (P)

International Laboratory for Microbiome Host Epigenetics, Department of Genetics, Evolution, Microbiology, and Immunology, Institute of Biology, University of Campinas, Campinas, SP 13083-862, Brazil; São Paulo Excellence Chair, Department of Genetics, Evolution, Microbiology, and Immunology, Institute of Biology, University of Campinas, Campinas, SP 13083-862, Brazil; School of Biological Sciences, University of Essex, Colchester, CO4 3SQ, UK.

Tiziana Bonaldi (T)

Department of Experimental Oncology, IEO, European Institute of Oncology IRCSS, 20139, Milan, Italy; Department of Oncology and Hematology-Oncology, University of Milan, 20122, Milan, Italy. Electronic address: tiziana.bonaldi@ieo.it.

Classifications MeSH